RSS worker, accused in neo-convert Anil Faisal murder case, hacked to death

Udupi, Apr 7: The district administrations of Udupi and Uttara Kannada districts have appealed to the state government to request Indian Council of Medical Research (ICMR) to allow COVID-19 tests at Manipal’s Kasturba Hospital.

Kasturba Hospital was granted approval by the ICMR to conduct tests on samples to detect the novel coronavirus on March 24, however it rescinded it later.

Udupi district Deputy Commissioner (DC) G Jagadeesha stated that the Council did not provide any reason for the cancellation of approval; his office has requested the Chief Secretary to pressurise the Council in granting approval again.

Bengaluru, Jan 3: Karnataka Chief Minister BS Yediyurappa on Friday clarified that Prime Minister Narendra Modi has assured him to consider all the demands made by his government.

"Prime Minister spoke to me personally and assured me of all help and suggested that I visit New Delhi and meet the concerned Ministers and apprise them about the state's problems and pending projects. He also directed me to prepare a detail report on this matter," Yediyurappa said in a statement.

He claimed that a section of media has misinterpreted his speech which was plain and honest towards the development of the state.

"A section of media has attached motive to my speech which was plain and honest in its content. Being in federal set up, there is nothing wrong with placing the facts before the Prime Minister and making submissions," the Chief Minister said.

"As a Chief Minister, I placed our state's problems and need for more funds for developmental activities. I pleaded before the Prime Minister for more funds to the relief work, the scientific and remunerative price for the farm produces, and special fund of Rs 50,000 crore for speeding up of on-going irrigation work. As it was farmers' meet, I felt it worthy and timely to plead the Prime Minister for more funds for all the developmental activities in the state," he said.

Asserting that Prime Minister Narendra Modi is a great visionary and his concern for the poor and farmers is unquestionable, he said: "When the whole world is appreciating his statesmanship and visionary zeal, it is in very bad taste for the media to attribute motives to my speech and relate it to the Prime Minister."

Yediyurappa requested media to show support to his government in the interest of the development of the state.

"I humbly request the electronic and print media not to misinterpret but support the government in the interest of the development of the state and interests of the people. I hope the media will respond to my request," he said.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.